Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

NCT01693315 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension
Eye Disease

Interventions

DRUG: AMA0076
DRUG: Placebo

Sponsor

Amakem, NV